Brown Ashley C, Hannan Riley T, Timmins Lucas H, Fernandez Janet D, Barker Thomas H, Guzzetta Nina A
From the Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina at Chapel Hill, Raleigh, North Carolina (A.C.B.); The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia (R.H., L.H.T., T.H.B.); Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia (L.H.T.); and Department of Anesthesiology, Emory University School of Medicine, Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia (J.D.F., N.A.G.).
Anesthesiology. 2016 May;124(5):1021-31. doi: 10.1097/ALN.0000000000001058.
Quantitative and qualitative differences in the hemostatic systems exist between neonates and adults, including the presence of "fetal" fibrinogen, a qualitatively dysfunctional form of fibrinogen that exists until 1 yr of age. The consequences of "fetal" fibrinogen on clot structure in neonates, particularly in the context of surgery-associated bleeding, have not been well characterized. Here, the authors examine the sequential changes in clotting components and resultant clot structure in a small sample of neonates undergoing cardiac surgery and cardiopulmonary bypass (CPB).
Blood samples were collected from neonates (n = 10) before surgery, immediately after CPB, and after the transfusion of cryoprecipitate (i.e., adult fibrinogen component). Clots were formed from patient samples or purified neonatal and adult fibrinogen. Clot structure was analyzed using confocal microscopy.
Clots formed from plasma obtained after CPB and after transfusion were more porous than baseline clots. Analysis of clots formed from purified neonatal and adult fibrinogen demonstrated that at equivalent fibrinogen concentrations, neonatal clots lack three-dimensional structure, whereas adult clots were denser with significant three-dimensional structure. Clots formed from a combination of purified neonatal and adult fibrinogen were less homogenous than those formed from either purified adult or neonatal fibrinogen.
The results of this study confirm that significant differences exist in clot structure between neonates and adults and that neonatal and adult fibrinogen may not integrate well. These findings suggest that differential treatment strategies for neonates should be pursued to reduce the demonstrated morbidity of blood product transfusion.
新生儿与成年人的止血系统在数量和质量上存在差异,包括存在“胎儿型”纤维蛋白原,这是一种功能失调的纤维蛋白原形式,直至1岁时仍存在。“胎儿型”纤维蛋白原对新生儿凝血结构的影响,尤其是在手术相关出血的情况下,尚未得到充分表征。在此,作者研究了一小部分接受心脏手术和体外循环(CPB)的新生儿凝血成分的顺序变化以及由此产生的凝血结构。
在手术前、CPB后即刻以及输注冷沉淀(即成人纤维蛋白原成分)后,从新生儿(n = 10)采集血样。用患者样本或纯化的新生儿及成人纤维蛋白原形成凝块。使用共聚焦显微镜分析凝血结构。
CPB后及输血后获得的血浆形成的凝块比基线凝块孔隙更多。对纯化的新生儿和成人纤维蛋白原形成的凝块分析表明,在纤维蛋白原浓度相等时,新生儿凝块缺乏三维结构,而成人凝块更致密,具有显著的三维结构。由纯化的新生儿和成人纤维蛋白原组合形成的凝块比由纯化的成人或新生儿纤维蛋白原形成的凝块更不均匀。
本研究结果证实新生儿和成年人的凝血结构存在显著差异,且新生儿和成人纤维蛋白原可能无法很好地整合。这些发现表明,应采取针对新生儿的差异化治疗策略,以降低已证实的血液制品输血发病率。